Tandem Diabetes Care Inc. (TNDM)

63.88
NASDAQ : Health Technology
Prev Close 61.55
Day Low/High 61.05 / 64.07
52 Wk Low/High 26.40 / 74.81
Avg Volume 1.26M
Exchange NASDAQ
Shares Outstanding 58.65M
Market Cap 3.61B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Tandem Diabetes Care To Present At The 29th Annual Piper Jaffray Healthcare Conference

Tandem Diabetes Care To Present At The 29th Annual Piper Jaffray Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will...

Tandem Diabetes Care To Present At The Stifel 2017 Healthcare Conference

Tandem Diabetes Care To Present At The Stifel 2017 Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will...

Human Factors Research Presented At DTM 2017 Demonstrates Ease Of Use And Effectiveness Of Computer-Based Training For Touchscreen Insulin Pump With Automated Insulin Delivery Feature

Human Factors Research Presented At DTM 2017 Demonstrates Ease Of Use And Effectiveness Of Computer-Based Training For Touchscreen Insulin Pump With Automated Insulin Delivery Feature

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today presented results from a Human Factors study conducted...

Tandem Diabetes Care Reports Third Quarter 2017 Financial Results

Tandem Diabetes Care Reports Third Quarter 2017 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended...

Tandem Diabetes Care To Provide All T:slim X2 Insulin Pump Features Approved In 2018 To Users At No Cost And Expands Existing Dexcom Welcome Offer For Animas Customers

Tandem Diabetes Care To Provide All T:slim X2 Insulin Pump Features Approved In 2018 To Users At No Cost And Expands Existing Dexcom Welcome Offer For Animas Customers

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it will make any new features approved...

Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release And Conference Call

Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its third quarter 2017 results after the...

Tandem Diabetes Care Announces Pricing Of $16.2 Million Underwritten Public Offering Of Common Stock And Warrants

Tandem Diabetes Care Announces Pricing Of $16.2 Million Underwritten Public Offering Of Common Stock And Warrants

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the pricing of an underwritten public offering...

Tandem Diabetes Care Announces Proposed Underwritten Public Offering Of Common Stock, Series A Warrants And Series B Warrants

Tandem Diabetes Care Announces Proposed Underwritten Public Offering Of Common Stock, Series A Warrants And Series B Warrants

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it is proposing to offer and sell shares...

Tandem Diabetes Care Announces Approval Of Reverse Stock Split

Tandem Diabetes Care Announces Approval Of Reverse Stock Split

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) previously announced that a proposal was approved at its Special Meeting of Stockholders, held September 7, 2017, authorizing its Board of Directors to amend the Company's...

Tandem Diabetes Care Reports Rapid Uptake And High Satisfaction Scores For T:slim X2 Insulin Pump Remote Software Update Following Launch Of CGM Integration

Tandem Diabetes Care Reports Rapid Uptake And High Satisfaction Scores For T:slim X2 Insulin Pump Remote Software Update Following Launch Of CGM Integration

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that one-third of t:slim X2™ Pump users...

Tandem Diabetes Care Announces FDA Approval And Launch Of T:slim X2 Insulin Pump With Dexcom G5 Mobile CGM Integration

Tandem Diabetes Care Announces FDA Approval And Launch Of T:slim X2 Insulin Pump With Dexcom G5 Mobile CGM Integration

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced U.

Tandem Diabetes Care Announces Issuance Of Patent Related To Remote Bolus Feature For Medical Infusion Pumps

Tandem Diabetes Care Announces Issuance Of Patent Related To Remote Bolus Feature For Medical Infusion Pumps

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the issuance of U.

Tandem Diabetes Care Announces Launch Of T:lock Connector For Its Insulin Pump Cartridges And Infusion Sets

Tandem Diabetes Care Announces Launch Of T:lock Connector For Its Insulin Pump Cartridges And Infusion Sets

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the launch of the t:lock™ Connector for...

Tandem Diabetes Care Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS)

Tandem Diabetes Care Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS)

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced enrollment of the first patients in an at-home...

Tandem Diabetes Care Announces Issuance Of Patent Related To Important Safety Features For Portable Infusion Pumps That Utilize Touchscreen Control

Tandem Diabetes Care Announces Issuance Of Patent Related To Important Safety Features For Portable Infusion Pumps That Utilize Touchscreen Control

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the issuance of U.

Tandem Diabetes Care To Present At The 2017 Wedbush PacGrow Healthcare Conference

Tandem Diabetes Care To Present At The 2017 Wedbush PacGrow Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will...

Tandem Diabetes Care Reports Second Quarter 2017 Financial Results

Tandem Diabetes Care Reports Second Quarter 2017 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended...

Tandem Diabetes Care Schedules Second Quarter 2017 Earnings Press Release And Conference Call

Tandem Diabetes Care Schedules Second Quarter 2017 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its second quarter 2017 results after the...

Tandem Diabetes Care Presents Findings From Predictive Low Glucose Suspend (PLGS) Feasibility Study And Announces Approval Of Investigational Device Exemption (IDE) For Pivotal Trial

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today presented results from a feasibility study for its...

Short Interest Makes 14.4% Move For TNDM

The most recent short interest data has been released for the 05/15/2017 settlement date, which shows a 357,165 share increase in total short interest for Tandem Diabetes Care Inc , to 2,838,888, an increase of 14.39% since 04/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Tandem Diabetes Care Reports First Quarter 2017 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended...

Tandem Diabetes Care To Present At The Deutsche Bank 42nd Annual Health Care Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will...

Tandem Diabetes Care Schedules First Quarter 2017 Earnings Press Release And Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its first quarter 2017 results after the...

Tandem Diabetes Care Launches New T:connect Diabetes Management Application Portal For Healthcare Providers

Tandem Diabetes Care ®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the launch of the t:connect ® HCP Portal.

Tandem Diabetes Care Announces Pricing Of Underwritten Public Offering Of Common Stock

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the pricing of an underwritten public offering...

Tandem Diabetes Care Announces Filing Of Registration Statement For Proposed Follow-on Public Offering Of Common Stock

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it has filed a registration statement on...

Tandem Diabetes Care Reports 2016 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the year and quarter...

Tandem Diabetes Care Announces Plans For Improved Infusion Set Connector Developed From Customer Feedback

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced plans to implement a new infusion set...

Tandem Diabetes Care Launches First Ever Remote Software Update For Insulin Pump Using A Personal Computer

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the release of a software update for...

TheStreet Quant Rating: D- (Sell)